Feedback / Questions
liraglutide (4P004) - 4P-Pharma
https://www.businesswire.com/news/home/20250326675460/en/Health-Canada-Authorizes-4Moving-Biotech-to-Launch-Phase-2a-INFLAM-MOTION-Clinical-Trial-for-Knee-Osteoarthritis
Mar 27, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next